NCT02503761View on ClinicalTrials.gov

Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Late Onset Neonatal Sepsis

Interventions

DRUG

Meropenem.

Infants in both groups will receive a loading dose of 20 mg/kg/dose every 8 hours for sepsis and 40 mg/kg/dose every 8 hours in meningitis and pseudomonas infection

All Listed Sponsors

lead

Mansoura University

OTHER

NCT02503761 - Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis | Biotech Hunter | Biotech Hunter